Qiao Xue-Ying, Wang Wei, Zhou Zhi-Guo, Gao Xian-Shu, Chang Joe Y
Department of Radiation Oncology, Hebei Medical University Fourth Hospital, Shijiazhuang, People's Republic of China.
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):396-402. doi: 10.1016/j.ijrobp.2007.06.031. Epub 2007 Sep 12.
To compare and analyze the effect of different clinical target volumes (CTVs) on survival rate after postoperative radiotherapy (RT) for esophageal squamous cell carcinoma (SCC).
We studied 102 patients who underwent postoperative RT after radical resection for esophageal SCC (T3/4 or N1). The radiation dose was > or =50 Gy. In the extensive portal group (E group, 43 patients), the CTV encompassed the bilateral supraclavicular region, all mediastinal lymph nodes, the anastomosis site, and the left gastric and pericardial lymphatic. In the regional portal group (R group, 59 patients), the CTV was confined to tumor bed and the lymph nodes in the immediate region of the primary lesion. The 1-, 3-, and 5-year survival rates were compared between the groups, and multivariate/univariate analysis for factors predicting survival was studied.
For the entire group, the 1-, 3- and 5-year survival rates were 76.3%, 50.5%, and 42.9%, respectively (median survival, 30 months). The 1-, 3-, and 5-year survival rates were 76.5%, 52.1%, and 41.3%, respectively, in the E group and 76.2%, 49.2%, and 44.6%, respectively, in the R group (not significant). According to the multivariate analysis, N stage, number of lymph nodes with metastatic disease, and tumor length were the independent prognostic factors for survival.
Using a regional portal in postoperative RT for esophageal SCC is not associated with compromised survival compared with extensive portal RT and therefore should be considered. N stage, number of affected lymph nodes, and tumor length predict poor survival.
比较和分析不同临床靶区(CTV)对食管鳞状细胞癌(SCC)术后放疗(RT)生存率的影响。
我们研究了102例食管SCC根治性切除术后接受术后放疗的患者(T3/4或N1)。放射剂量≥50 Gy。在扩大野组(E组,43例患者)中,CTV包括双侧锁骨上区、所有纵隔淋巴结、吻合口部位以及左胃和心包淋巴管。在区域野组(R组,59例患者)中,CTV局限于肿瘤床和原发灶紧邻区域的淋巴结。比较两组的1年、3年和5年生存率,并研究预测生存的因素的多因素/单因素分析。
对于整个组,1年、3年和5年生存率分别为76.3%、50.5%和42.9%(中位生存期,30个月)。E组的1年、3年和5年生存率分别为76.5%、52.1%和41.3%,R组分别为76.2%、49.2%和44.6%(无显著差异)。根据多因素分析,N分期、有转移疾病的淋巴结数量和肿瘤长度是生存的独立预后因素。
与扩大野放疗相比,在食管SCC术后放疗中使用区域野与生存率降低无关,因此应予以考虑。N分期、受累淋巴结数量和肿瘤长度预示着生存不良。